Authors: Gelmon, KA Latreille, J Tolcher, A Genier, L Fisher, B Forand, D D'Aloisio, S Vernillet, L Daigneault, L Lebecq, A Besenval, M Eisenhauer, E

Citation: Ka. Gelmon et al., Phase I dose-finding study of a new taxane, RPR 109881A, administered as aone-hour intravenous infusion days 1 and 8 to patients with advanced solidtumors, J CL ONCOL, 18(24), 2000, pp. 4098-4108